152 related articles for article (PubMed ID: 29186874)
1. Do Cervical Cancer Patients Diagnosed with Opportunistic Screening Live Longer? An Arkhangelsk Cancer Registry Study.
Roik EE; Nieboer E; Kharkova OA; Grjibovski AM; Postoev VA; Odland JØ
Int J Environ Res Public Health; 2017 Nov; 14(12):. PubMed ID: 29186874
[TBL] [Abstract][Full Text] [Related]
2. About invasive cervical cancer: a French population based study between 1998 and 2010.
Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia.
Kuo HY; Lin ZZ; Kuo R; Shau WY; Lai CL; Yang YY; Shao YY; Hsu C; Cheng WF; Cheng AL; Yang JC; Lai MS
Oncologist; 2015 Sep; 20(9):1051-7. PubMed ID: 26240133
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
5. Elderly women above screening age diagnosed with cervical cancer have a worse prognosis.
Darlin L; Borgfeldt C; Widén E; Kannisto P
Anticancer Res; 2014 Sep; 34(9):5147-51. PubMed ID: 25202106
[TBL] [Abstract][Full Text] [Related]
6. Cervical Cancer in Women Aged 35 Years and Younger.
Pelkofski E; Stine J; Wages NA; Gehrig PA; Kim KH; Cantrell LA
Clin Ther; 2016 Mar; 38(3):459-66. PubMed ID: 26899314
[TBL] [Abstract][Full Text] [Related]
7. Incidence, mortality and determinants of survival from cervical cancer in Northwest Russia: a registry-based cohort study.
Grjibovski AM; Dubovichenko D; Saduakassova S; Zhatkanbayeva G; Omarova G; Shalgumbayeva G; Valkova L; Valkov MY
Int Health; 2018 Mar; 10(2):92-99. PubMed ID: 29432549
[TBL] [Abstract][Full Text] [Related]
8. Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer.
An Q; Liu W; Yang Y; Yang B
BMC Cancer; 2020 Jul; 20(1):691. PubMed ID: 32711484
[TBL] [Abstract][Full Text] [Related]
9. Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964-1988.
Sigurdsson K; Hrafnkelsson J; Geirsson G; Gudmundsson J; Salvarsdóttir A
Gynecol Oncol; 1991 Oct; 43(1):64-70. PubMed ID: 1959790
[TBL] [Abstract][Full Text] [Related]
10. Advancing age and cervical cancer screening and prognosis.
Sawaya GF; Sung HY; Kearney KA; Miller M; Kinney W; Hiatt RA; Mandelblatt J
J Am Geriatr Soc; 2001 Nov; 49(11):1499-504. PubMed ID: 11890589
[TBL] [Abstract][Full Text] [Related]
11. Significance of uterine corpus tumor invasion in early-stage cervical cancer.
Matsuo K; Machida H; Blake EA; Takiuchi T; Mikami M; Roman LD
Eur J Surg Oncol; 2017 Apr; 43(4):725-734. PubMed ID: 28215507
[TBL] [Abstract][Full Text] [Related]
12. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
13. Prognostic utility of serum YKL-40 in patients with cervical cancer.
Roslind A; Palle C; Johansen JS; Christensen IJ; Nielsen HJ; Mosgaard BJ
Scand J Clin Lab Invest; 2020 Dec; 80(8):687-693. PubMed ID: 33186077
[TBL] [Abstract][Full Text] [Related]
14. A survival study of uterine cervical patients in the North East India: Hospital-cancer registry-based analysis.
Kataki AC; Sharma JD; Krishnatreya M; Baishya N; Barmon D; Deka P; Kalita M
J Cancer Res Ther; 2018; 14(5):1089-1093. PubMed ID: 30197354
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in cervical cancer survival over time.
Rauh-Hain JA; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
Cancer; 2013 Oct; 119(20):3644-52. PubMed ID: 23913530
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
17. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
18. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
19. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
20. Value of Intratumoral Metabolic Heterogeneity and Quantitative
Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM
AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078
[No Abstract] [Full Text] [Related]
[Next] [New Search]